{
    "clinical_study": {
        "@rank": "2996", 
        "arm_group": {
            "arm_group_label": "Diagnostic (ultrasound)", 
            "arm_group_type": "Experimental", 
            "description": "Patients undergo breast ultrasound."
        }, 
        "brief_summary": {
            "textblock": "This pilot clinical trial studies ultrasound in detecting lymph node metastasis in older\n      patients with undergoing breast sonography. Diagnostic procedures, such as ultrasound, may\n      help find breast cancer and find out how far the disease has spread"
        }, 
        "brief_title": "Ultrasound in Detecting Lymph Node Metastasis in Older Patients Undergoing Breast Sonography", 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To develop a reliable and consistent set of guidelines for utilizing diagnostic\n      ultrasound to assess axillary lymph nodes for patient suspicious of breast cancer with\n      possible nodal metastasis.\n\n      SECONDARY OBJECTIVES:\n\n      I. To explore whether the data collected can be used for pathologic validation of metastatic\n      disease.\n\n      OUTLINE:\n\n      Patients undergo breast ultrasound."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients referred for a breast ultrasound\n\n          -  Patients who have had a mammogram with a Breast Imaging Reporting and Data System\n             (BIRADS) of >= 4\n\n          -  Patients who are undiagnosed for breast cancer\n\n        Exclusion Criteria:\n\n          -  Patients who have had breast cancer surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "55 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01681901", 
            "org_study_id": "OSU-06010", 
            "secondary_id": "NCI-2012-01176"
        }, 
        "intervention": {
            "arm_group_label": "Diagnostic (ultrasound)", 
            "description": "Undergo ultrasound", 
            "intervention_name": "ultrasound imaging", 
            "intervention_type": "Procedure", 
            "other_name": [
                "ultrasonography", 
                "ultrasound", 
                "ultrasound test"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 5, 2012", 
        "link": {
            "description": "The Jamelsine", 
            "url": "http://cancer.osu.edu"
        }, 
        "location": {
            "contact": {
                "email": "Kevin.Evans@osumc.edu", 
                "last_name": "Kevin Evans, PhD,RT,RDMS,RVS", 
                "phone": "614-688-4535"
            }, 
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43210"
                }, 
                "name": "The Ohio State University Medical Center"
            }, 
            "investigator": {
                "last_name": "Kevin Evans, PhD,RT,RDMS,RVS", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Lymph Node Evaluation in the Axilla of Symptomatic Older Women During Breast Sonography.", 
        "overall_official": {
            "affiliation": "Ohio State University Comprehensive Cancer Center", 
            "last_name": "Kevin Evans", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The proposed methodology will be considered unfeasible if the proportion of successful evaluations is =< 0.7.", 
            "measure": "Proportion of successful evaluations, defined as the consistent capture of the data for geometry, morphology, qualitative vascular information, and quantitative vascular information on 3 axillary lymph nodes", 
            "safety_issue": "No", 
            "time_frame": "at 15 minutes following breast sonogram"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01681901"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University Comprehensive Cancer Center", 
            "investigator_full_name": "Kevin Evans", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Descriptive statistics, such as means, proportions and standard deviations, will be summarized. The longitudinal-transverse ratio will be investigated for cutoff points that yield high sensitivity and to see if results are consistent with prior studies suggesting a ratio of 1.5 or less is indicative of abnormality. The percent agreement between the resulting diagnostic criteria and the surgical/pathological results will be assessed.", 
                "measure": "Accuracy of lymph node geometry, measured with a longitudinal and transverse ratio, to determine guidelines for characterizing micro metastases to the lymph nodes", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Descriptive statistics, such as means, proportions and standard deviations, will be summarized. The percent agreement between the resulting diagnostic criteria and the surgical/pathological results will be assessed.", 
                "measure": "Accuracy of lymph node morphology, assessed for shape and echogenicity, to determine guidelines for characterizing micro metastases to the lymph nodes", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Descriptive statistics, such as means, proportions and standard deviations, will be summarized. The percent agreement between the resulting diagnostic criteria and the surgical/pathological results will be assessed.", 
                "measure": "Accuracy of lymph node vascularity, assessed with color doppler, to determine guidelines for characterizing micro metastases to the lymph nodes", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Descriptive statistics, such as means, proportions and standard deviations, will be summarized. The percent agreement between the resulting diagnostic criteria and the surgical/pathological results will be assessed.", 
                "measure": "Accuracy of lymphatic flow, measured with spectral doppler, to determine guidelines for characterizing micro metastases to the lymph nodes", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Ohio State University Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kevin Evans", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2006", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}